Announce Date | 08/01/2024 |
EPS Normalized Actual | $-0.20596 (Miss by $-0.10596) |
EPS GAAP Actual | $-0.20596 (Miss by $-0.10596) |
Revenue Actual | $0.166258B |
Revenue Surprise | Beat by $166.258M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 2.1 | 6.14 | 1.41527 | 3.05845 | 1 |
Dec 2027 | 2.4 | 5.38 | 1.5699 | 3.88731 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Mar 2022) | 0.49 | 0.49 | 0.166258B | 63.93% | 166.26M |
FQ4 2021 (Dec 2021) | 0.28 | 0.28 | 0.099109B | 100% | 99.11M |
FQ3 2021 (Sep 2021) | 0.24 | 0.24 | 0.099754B | 58.88% | 99.75M |
FQ2 2021 (Jun 2021) | 0.16 | 0.16 | 0.073118B | 58.44% | 73.12M |
FQ1 2021 (Mar 2021) | 0.1 | 0.1 | 0.059971B | 65.45% | 59.97M |
FQ4 2020 (Dec 2020) | -0.195039 | -0.195039 | 0B | NAN% | 0M |
FQ3 2020 (Sep 2020) | 0.093811 | 0.093811 | 0.041022B | 100% | 41.02M |
FQ2 2020 (Jun 2020) | -0.92 | -0.92 | 0.030391B | 100% | 30.39M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 0.2354 | -- | 0.2354 | 0.2354 | 2 |
FQ3 2027 (Jul 2027) | 0.2346 | -- | 0.2346 | 0.2346 | 2 |
FQ2 2027 (Jun 2027) | 0.2346 | -- | 0.14413 | 0.30522 | 4 |
FQ1 2027 (Mar 2027) | 0.2815 | -- | 0.17295 | 0.36623 | 4 |
FQ4 2026 (Oct 2026) | 0.36 | -- | 0.27201 | 0.434 | 1 |
FQ3 2026 (Jul 2026) | 0.36 | -- | 0.27201 | 0.434 | 1 |
FQ2 2026 (Jun 2026) | 0.36 | -- | 0.27652 | 0.43464 | 1 |
FQ1 2026 (Mar 2026) | 0.36 | -- | 0.27652 | 0.43464 | 1 |
FQ4 2025 (Oct 2025) | 0.050889 | -- | 0.03845056 | 0.06135015 | 2 |
FQ3 2025 (Sep 2025) | 0.15399 | -- | 0.13825 | 0.16913 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 0.17B | -- | 0.17B | 0.17B | 2 |
FQ3 2027 (Jul 2027) | 0.17B | -- | 0.17B | 0.17B | 2 |
FQ2 2027 (Jun 2027) | 0.17B | -- | 0.12B | 0.21B | 3 |
FQ1 2027 (Mar 2027) | 0.17B | -- | 0.12B | 0.21B | 3 |
FQ4 2026 (Oct 2026) | 0.18B | -- | 0.15B | 0.21B | 2 |
FQ3 2026 (Jul 2026) | 0.18B | -- | 0.15B | 0.21B | 2 |
FQ2 2026 (Jun 2026) | 0.18B | -- | 0.15B | 0.21B | 2 |
FQ1 2026 (Mar 2026) | 0.18B | -- | 0.15B | 0.21B | 2 |
FQ4 2025 (Oct 2025) | 0.12B | -- | 0.09B | 0.13B | 1 |
FQ3 2025 (Sep 2025) | 0.14B | -- | 0.13B | 0.15B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | 0.49 | 0.49 | 100% | |
FQ4 2021 (Dec 2021) | 0.28 | 0.28 | 100% | |
FQ3 2021 (Sep 2021) | 0.24 | 0.24 | 100% | |
FQ2 2021 (Jun 2021) | 0.16 | 0.16 | 100% | |
FQ1 2021 (Mar 2021) | 0.1 | 0.1 | 100% | |
FQ4 2020 (Dec 2020) | -0.195039 | -0.195039 | 100% | |
FQ3 2020 (Sep 2020) | 0.093811 | 0.093811 | 100% | |
FQ2 2020 (Jun 2020) | -0.92 | -0.92 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | $0B | $0.17B | $166.26M | 100% |
FQ4 2021 (Dec 2021) | $0B | $0.1B | $99.11M | 100% |
FQ3 2021 (Sep 2021) | $0B | $0.1B | $99.75M | 100% |
FQ2 2021 (Jun 2021) | $0B | $0.07B | $73.12M | 100% |
FQ1 2021 (Mar 2021) | $0B | $0.06B | $59.97M | 100% |
FQ4 2020 (Dec 2020) | $0B | $0B | $0M | NAN% |
FQ3 2020 (Sep 2020) | $0B | $0.04B | $41.02M | 100% |
FQ2 2020 (Jun 2020) | $0B | $0.03B | $30.39M | 100% |